obesity drugs glp-1 news today health pharma october 2025 Outlook for obesity in 2025: more Dozens of new obesity drugs

Confirmatory testing using GC-MS or LC-MS/MS methodology is standard practice for employment drug testing and is explicitly required in DOT and federal workplace programs before any adverse action can be taken

GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone that helps regulate appetite, digestion, and insulin release, promoting a sense of fullness after meals

American Society of Nuclear Cardiology

doi: 10.1038/s41366-020-0535-5 79

Binding of GLP-1 to GLP1R has multiple effects, including enhancing insulin secretion from pancreatic beta cells in response to glucose, increasing insulin expression, preventing beta-cell apoptosis, promoting the formation of new beta cells, reducing glucagon secretion, slowing down stomach emptying, promoting satiety, and improving glucose disposal in peripheral tissues

Mizumoto J